Dermatology Devices Market by Type (Diagnostic Devices (Dermatoscopes, Imaging Devices), Treatment Devices (Laser, Cryotherapy, Liposuction), Application (Skin Cancer, Acne, Psoriasis, Skin Rejuvenation, Tattoo Removal) - Global Forecast to 2027
The global dermatology devices market is projected to reach USD 11.3 billion by 2027 from USD 6.2 billion in 2022, at a CAGR of 12.7% during the forecasted period. Dermatology devices help dermatologists and surgeons in diagnosing and treating skin disorders. These devices are used by various medical care providers, such as hospitals, dermatology clinics, physician offices, and academic research institutes. The rising incidence of skin diseases and increasing awareness of aesthetic procedures are the primary growth drivers for the dermatology devices market. The expansion of healthcare infrastructure in developing regions is expected to provide growth opportunities to players operating in this market.
“The imaging devices areaccounted to hold the largest share of the dermatology diagnostic devices market, by type in 2021.”
Based on type, the dermatology diagnostic devices market is segmented into imaging devices, dermatoscopes, and microscopes. In 2021, the imaging devices segment accounted for the largest share of the dermatology diagnostic devices market. The large share of this segment can be attributed to technological advancements and the increasing incidence of skin diseases.
“The skin cancer diagnosis are accounted to hold the largest share of the dermatology diagnostic devices market, by application in 2021.”
Based on application, the dermatology diagnostic devices market is segmented into skin cancer diagnosis and other diagnostic applications. In 2021, the skin cancer diagnosis segment accounted for the largest share of the market. The large share of this segment can be attributed to the rising incidence of skin cancer.
“Asia Pacific commanded the highest CAGR of the dermatology devices duringforecasted period.”
Based on region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. During forecasted period, Asia Pacific has the highest CAGR of the dermatology devices market. The highest CAGR of this regional segment can be attributed to factors such as the large population, rising standards of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and enhanced awareness about dermatology devices.
Breakdown of supply-side primary interviews, by company type, designation, and region:
List of Companies Profiled in the Report
This report studies the dermatology devices market based on type, application, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total dermatology devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
“The imaging devices areaccounted to hold the largest share of the dermatology diagnostic devices market, by type in 2021.”
Based on type, the dermatology diagnostic devices market is segmented into imaging devices, dermatoscopes, and microscopes. In 2021, the imaging devices segment accounted for the largest share of the dermatology diagnostic devices market. The large share of this segment can be attributed to technological advancements and the increasing incidence of skin diseases.
“The skin cancer diagnosis are accounted to hold the largest share of the dermatology diagnostic devices market, by application in 2021.”
Based on application, the dermatology diagnostic devices market is segmented into skin cancer diagnosis and other diagnostic applications. In 2021, the skin cancer diagnosis segment accounted for the largest share of the market. The large share of this segment can be attributed to the rising incidence of skin cancer.
“Asia Pacific commanded the highest CAGR of the dermatology devices duringforecasted period.”
Based on region, the dermatology devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. During forecasted period, Asia Pacific has the highest CAGR of the dermatology devices market. The highest CAGR of this regional segment can be attributed to factors such as the large population, rising standards of living, growing demand for quality medical care, increasing healthcare spending, government initiatives, and enhanced awareness about dermatology devices.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2(45%), and Tier 3 (35%)
- By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
- By Region: North America (33%), Europe (24%), AsiaPacific(27%), and Rest of the World (16%)
List of Companies Profiled in the Report
- Alma Lasers, Ltd. (Israel)
- Cutera, Inc. (US)
- Cynosure Inc. (US)
- El.En. S.P.A. (Italy)
- Lumenis Ltd. (Israel)
- Solta Medical (US)
- Bruker Corporation (US)
- Carl Zeiss (Germany)
- HEINE Optotechnik GmbH & Co. KG (Germany)
- Michelson Diagnostics Ltd. (UK)
- PhotoMedex, Inc. (US)
- Leica Microsystems (US)
- Olympus Corporation (Japan)
- Syneron Medical Ltd. (US)
- Genesis Biosystems, Inc. (US)
- Canfield Scientific, Inc. (US)
- Candela (US)
- DermLite (US)
- Beijing Toplaser Technology Co., Ltd. (China)
- Aerolase (US)
- FotoFinder Systems GmbH (Germany)
- Bovie (US)
This report studies the dermatology devices market based on type, application, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total dermatology devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on dermatology devices offered by the top 22 players in the endoscope reprocessing market. The report analyzes the dermatology devices markettype,application,and region.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the dermatology devices market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the dermatology devices market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY TREATMENT DEVICES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY DIAGNOSTIC DEVICES
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT/FACTOR ANALYSIS
TABLE 1 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 11 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 DERMATOLOGY DEVICES MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 DERMATOLOGY DEVICES MARKET OVERVIEW
FIGURE 16 RISING INCIDENCE OF SKIN DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (2021)
FIGURE 17 IMAGING DEVICES SEGMENT DOMINATED APAC MARKET IN 2021
4.3 GEOGRAPHICAL SNAPSHOT OF DERMATOLOGY DEVICES MARKET
FIGURE 18 JAPAN TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of skin disorders
5.2.1.2 Availability of technologically advanced and user-friendly products
5.2.1.3 Growing adoption of minimally invasive and non-invasive aesthetic procedures
5.2.1.4 Rising adoption of aesthetic procedures among geriatric individuals
FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY
(2011 VS. 2015 VS. 2030)
FIGURE 21 INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030)
5.2.1.5 Increasing investments, funds, and grants by public-private organizations
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory policies for medical devices
5.2.2.2 Clinical risks and complications associated with dermatology procedures
5.2.2.3 High cost of diagnostic imaging systems
5.2.2.4 Declining reimbursements and increasing regulatory
burden in the US
TABLE 3 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007–2019
5.2.3 OPPORTUNITIES
5.2.3.1 Growing medical devices industry in emerging economies
FIGURE 22 MEDICAL DEVICES MARKET, 2016–2020 (USD BILLION)
5.2.3.2 Increasing disposable income and expanding middle-class population
5.2.4 CHALLENGES
5.2.4.1 Competitive pricing by low-cost manufacturers and availability of low-cost substitutes
5.2.4.2 Dearth of trained professionals
5.2.5 TRENDS
5.2.5.1 Importance of artificial intelligence and teleradiology in skin disorder diagnosis and treatment
5.3 COVID-19 IMPACT ANALYSIS
5.4 RANGES/SCENARIOS
5.4.1 DERMATOLOGY DEVICES MARKET
FIGURE 23 REALISTIC SCENARIO
FIGURE 24 PESSIMISTIC SCENARIO
FIGURE 25 OPTIMISTIC SCENARIO
5.5 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DERMATOLOGY DEVICES
5.5.1 NORTH AMERICA
5.5.1.1 US
TABLE 5 US FDA MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
5.5.3.2 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 India
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 26 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
5.8 VALUE CHAIN ANALYSIS
FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.9 ECOSYSTEM ANALYSIS
FIGURE 28 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN ECOSYSTEM
FIGURE 29 KEY PLAYERS IN DERMATOLOGY DEVICES MARKET ECOSYSTEM
5.10 TECHNOLOGY ANALYSIS
5.11 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 10 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF
CONFERENCES & EVENTS
5.12 PATENT ANALYSIS
5.12.1 PATENT TRENDS FOR DERMATOLOGY DEVICES
FIGURE 30 PATENT TRENDS FOR DERMATOSCOPES, JANUARY 2011–JUNE 2022
FIGURE 31 PATENT TRENDS FOR LIPOSUCTION DEVICES, JANUARY 2011–JUNE 2022
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR DERMATOSCOPE PATENTS, JANUARY 2011—JUNE 2022
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR LIPOSUCTION DEVICE PATENTS, JANUARY 2011—JUNE 2022
5.13 TRADE ANALYSIS
TABLE 11 IMPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 12 EXPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017–2021 (USD MILLION)
5.14 PRICING ANALYSIS
TABLE 13 AVERAGE SELLING PRICES OF DERMATOLOGY DEVICES
TABLE 14 COST OF DERMATOLOGY TREATMENT DEVICES
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES
TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES (%)
5.15.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR DERMATOLOGY DEVICE MANUFACTURERS
FIGURE 36 REVENUE SHIFT FOR DERMATOLOGY DEVICES
6 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 17 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 IMAGING DEVICES
6.2.1 MRI, ULTRASOUND, CT, AND OCT ARE WIDELY USED IN DERMATOLOGY DISEASE DIAGNOSIS
TABLE 18 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES, BY REGION, 2020–2027 (USD MILLION)
6.3 DERMATOSCOPES
6.3.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH
TABLE 19 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES, BY REGION, 2020–2027 (USD MILLION)
6.4 MICROSCOPES
6.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES —
A KEY FACTOR DRIVING SEGMENT GROWTH
TABLE 20 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY REGION, 2020–2027 (USD MILLION)
7 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 21 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 SKIN CANCER DIAGNOSIS
7.2.1 RISING PREVALENCE OF SKIN CANCER AND INCREASING AWARENESS ABOUT EARLY DIAGNOSIS TO DRIVE SEGMENT GROWTH
TABLE 22 NUMBER OF MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
TABLE 23 NUMBER OF NON-MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
TABLE 24 NUMBER OF MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
TABLE 25 NUMBER OF NON-MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
TABLE 26 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION)
7.3 OTHER DIAGNOSTIC APPLICATIONS
TABLE 27 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE
8.1 INTRODUCTION
TABLE 28 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2 LIGHT THERAPY DEVICES
8.2.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES
TO DRIVE SEGMENT GROWTH
TABLE 29 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION)
8.3 LASERS
8.3.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS
TABLE 30 DERMATOLOGY TREATMENT DEVICES MARKET FOR LASERS, BY REGION, 2020–2027 (USD MILLION)
8.4 ELECTROSURGICAL EQUIPMENT
8.4.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH
TABLE 31 DERMATOLOGY TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2020–2027 (USD MILLION)
8.5 LIPOSUCTION DEVICES
8.5.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH
TABLE 32 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION, 2020–2027 (USD MILLION)
8.6 MICRODERMABRASION DEVICES
8.6.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH
TABLE 33 DERMATOLOGY TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2020–2027 (USD MILLION)
8.7 CRYOTHERAPY DEVICES
8.7.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ITS ADOPTION
TABLE 34 DERMATOLOGY TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION)
9 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 35 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2 HAIR REMOVAL
9.2.1 IPL, DIODE, ND:YAG, AND RUBY LASERS ARE WIDELY USED IN HAIR REMOVAL PROCEDURES
TABLE 36 LASER HAIR REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 37 DERMATOLOGY TREATMENT DEVICES MARKET FOR HAIR REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.3 SKIN REJUVENATION
9.3.1 GROWING DEMAND FOR SAFE AND EFFECTIVE SKIN REJUVENATION TREATMENTS TO PROPEL SEGMENT GROWTH
TABLE 38 DERMATOLOGY TREATMENT DEVICES MARKET FOR SKIN REJUVENATION, BY REGION, 2020–2027 (USD MILLION)
9.4 ACNE, PSORIASIS, AND TATTOO REMOVAL
9.4.1 EMERGENCE OF LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE SEGMENT GROWTH
TABLE 39 LASER TATTOO REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 40 DERMATOLOGY TREATMENT DEVICES MARKET FOR ACNE, PSORIASIS, AND TATTOO REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.5 WRINKLE REMOVAL AND SKIN RESURFACING
9.5.1 RAPIDLY GROWING AGING POPULATION TO DRIVE SEGMENT GROWTH
TABLE 41 SKIN RESURFACING PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 42 DERMATOLOGY TREATMENT DEVICES MARKET FOR WRINKLE REMOVAL AND SKIN RESURFACING, BY REGION, 2020–2027 (USD MILLION)
9.6 BODY CONTOURING AND FAT REMOVAL
9.6.1 RISING AWARENESS OF RECONSTRUCTIVE SURGERY
TO DRIVE SEGMENT GROWTH
TABLE 43 LIPOSUCTION PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 44 NON-INVASIVE FAT REDUCTION (COOLSCULPTING, LIPOSONIX, EMSCULPT, VANQUISH, AND ZERONA) PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 45 DERMATOLOGY TREATMENT DEVICES MARKET FOR BODY CONTOURING AND FAT REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.7 VASCULAR AND PIGMENTED LESION REMOVAL
9.7.1 EMERGENCE OF LASER TECHNOLOGY FOR VASCULAR LESION REMOVAL TO DRIVE SEGMENT GROWTH
TABLE 46 DERMATOLOGY TREATMENT DEVICES MARKET FOR VASCULAR AND PIGMENTED LESION REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.8 WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT
9.8.1 CRYOTHERAPY IS WIDELY USED IN WART AND SKIN TAG TREATMENT
TABLE 47 DERMATOLOGY TREATMENT DEVICES MARKET FOR WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
9.9 OTHER TREATMENT APPLICATIONS
TABLE 48 DERMATOLOGY TREATMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
10 DERMATOLOGY DEVICES MARKET, BY REGION
10.1 INTRODUCTION
TABLE 49 DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US dominated North American market in 2021
TABLE 55 US: KEY MACROINDICATORS
TABLE 56 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 57 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 58 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 59 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 60 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Technological advancements in dermatology devices to drive market growth in Canada
TABLE 64 CANADA: KEY MACROINDICATORS
TABLE 65 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 69 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 70 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.1 FRANCE
10.3.1.1 Laws in France regarding cosmetic surgery are restrictive as compared with those in other countries
TABLE 74 FRANCE: KEY MACROINDICATORS
TABLE 75 FRANCE: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 76 FRANCE: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 77 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 80 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Rising disposable income to drive dermatology device adoption in Germany
TABLE 81 GERMANY: KEY MACROINDICATORS
TABLE 82 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 83 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 84 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 85 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 86 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Increasing focus on facial dermatology to aid market growth
TABLE 90 UK: KEY MACROINDICATORS
TABLE 91 UK: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 92 UK: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 93 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 96 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising number of plastic surgeons to drive market growth
TABLE 97 ITALY: KEY MACROINDICATORS
TABLE 98 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 99 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 100 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 101 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 102 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 105 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing demand for cosmetic procedures to drive market growth
TABLE 106 SPAIN: KEY MACROINDICATORS
TABLE 107 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 108 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 109 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 110 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 111 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 115 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)
TABLE 116 RUSSIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 117 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 120 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 38 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT
TABLE 121 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 122 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of APAC market in 2021
TABLE 126 JAPAN: KEY MACROINDICATORS
TABLE 127 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 128 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 129 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 130 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 131 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Rising healthcare expenditure to drive market growth in China
TABLE 135 CHINA: KEY MACROINDICATORS
TABLE 136 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Improving healthcare infrastructure to drive market growth in India
TABLE 140 INDIA: KEY MACROINDICATORS
TABLE 141 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 142 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 143 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 144 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 145 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 148 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 149 THAILAND: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 150 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 153 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 154 MEXICO: KEY MACROINDICATORS
TABLE 155 BRAZIL: KEY MACROINDICATORS
TABLE 156 BRAZIL: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 157 MEXICO: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 158 ROW: DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 159 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 162 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
11.3 REVENUE ANALYSIS
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY TREATMENT DEVICES MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 40 DERMATOLOGY TREATMENT DEVICES MARKET SHARE ANALYSIS, 2020
TABLE 164 DERMATOLOGY TREATMENT DEVICES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PARTICIPANTS
11.5.4 PERVASIVE PLAYERS
FIGURE 41 GLOBAL DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 42 DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
11.7 COMPETITIVE BENCHMARKING
TABLE 165 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY SMES/START-UPS
TABLE 166 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF SMES/START-UPS
11.8 COMPANY FOOTPRINT
TABLE 167 OVERALL FOOTPRINT OF COMPANIES
TABLE 168 PRODUCT FOOTPRINT OF COMPANIES
TABLE 169 REGIONAL FOOTPRINT OF COMPANIES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 DEALS
TABLE 170 DEALS, JANUARY 2019–MAY 2022
11.9.2 PRODUCT LAUNCHES & APPROVALS
TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MAY 2022
11.9.3 EXPANSIONS
TABLE 172 EXPANSIONS, JANUARY 2019–MAY 2022
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ALMA LASERS, LTD. (A SUBSIDIARY OF SISRAM MEDICAL LTD.)
TABLE 173 ALMA LASERS, LTD.: BUSINESS OVERVIEW
FIGURE 43 SISRAM MEDICAL LTD.: COMPANY SNAPSHOT (2021)
12.1.2 CUTERA, INC.
TABLE 174 CUTERA, INC.: BUSINESS OVERVIEW
FIGURE 44 CUTERA, INC.: COMPANY SNAPSHOT (2021)
12.1.3 CYNOSURE, INC.
TABLE 175 CYNOSURE, INC.: BUSINESS OVERVIEW
12.1.4 EL.EN. S.P.A.
TABLE 176 EL.EN. S.P.A.: BUSINESS OVERVIEW
FIGURE 45 EL.EN. S.P.A.: COMPANY SNAPSHOT (2021)
12.1.5 LUMENIS, LTD. (A SUBSIDIARY OF BOSTON SCIENTIFIC)
TABLE 177 LUMENIS, LTD.: BUSINESS OVERVIEW
FIGURE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2021)
12.1.6 SOLTA MEDICAL (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
TABLE 178 SOLTA MEDICAL: BUSINESS OVERVIEW
FIGURE 47 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021)
12.1.7 DERMLITE
TABLE 179 DERMLITE: BUSINESS OVERVIEW
12.1.8 BRUKER CORPORATION
TABLE 180 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 CARL ZEISS
TABLE 181 CARL ZEISS: BUSINESS OVERVIEW
FIGURE 49 CARL ZEISS: COMPANY SNAPSHOT (2021)
12.1.10 GENESIS BIOSYSTEMS, INC.
TABLE 182 GENESIS BIOSYSTEMS, INC.: BUSINESS OVERVIEW
12.1.11 HEINE OPTOTECHNIK GMBH & CO. KG
TABLE 183 HEINE OPTOTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
12.1.12 MICHELSON DIAGNOSTICS, LTD.
TABLE 184 MICHELSON DIAGNOSTICS, LTD.: BUSINESS OVERVIEW
12.1.13 PHOTOMEDEX, INC. (A SUBSIDIARY OF DS HEALTHCARE GROUP)
TABLE 185 PHOTOMEDEX, INC.: BUSINESS OVERVIEW
12.1.14 FOTOFINDER SYSTEMS GMBH
TABLE 186 FOTOFINDER SYSTEMS GMBH: BUSINESS OVERVIEW
12.1.15 LEICA MICROSYSTEMS (A SUBSIDIARY OF DANAHER CORPORATION)
TABLE 187 LEICA MICROSYSTEMS: BUSINESS OVERVIEW
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.16 OLYMPUS CORPORATION
TABLE 188 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 51 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
12.1.17 CANDELA CORPORATION
TABLE 189 CANDELA CORPORATION: BUSINESS OVERVIEW
FIGURE 52 CANDELA CORPORATION: COMPANY SNAPSHOT (2020)
12.1.18 CANFIELD SCIENTIFIC, INC.
TABLE 190 CANFIELD SCIENTIFIC, INC.: BUSINESS OVERVIEW
12.1.19 BEIJING TOPLASER TECHNOLOGY CO., LTD.
TABLE 191 BEIJING TOPLASER TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SYNERON MEDICAL LTD. (A PART OF APAX PARTNERS)
12.2.2 AEROLASE
12.2.3 BOVIE (A SUBSIDIARY OF SYMMETRY SURGICAL)
TABLE 192 SYMMETRY SURGICAL: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY TREATMENT DEVICES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY – BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF DERMATOLOGY DIAGNOSTIC DEVICES
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT/FACTOR ANALYSIS
TABLE 1 RISK ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 11 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 DERMATOLOGY DEVICES MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 DERMATOLOGY DEVICES MARKET OVERVIEW
FIGURE 16 RISING INCIDENCE OF SKIN DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE (2021)
FIGURE 17 IMAGING DEVICES SEGMENT DOMINATED APAC MARKET IN 2021
4.3 GEOGRAPHICAL SNAPSHOT OF DERMATOLOGY DEVICES MARKET
FIGURE 18 JAPAN TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 DERMATOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of skin disorders
5.2.1.2 Availability of technologically advanced and user-friendly products
5.2.1.3 Growing adoption of minimally invasive and non-invasive aesthetic procedures
5.2.1.4 Rising adoption of aesthetic procedures among geriatric individuals
FIGURE 20 INCREASE IN GERIATRIC POPULATION, BY COUNTRY
(2011 VS. 2015 VS. 2030)
FIGURE 21 INCREASE IN PROPORTION OF GERIATRIC INDIVIDUALS IN OVERALL POPULATION, BY COUNTRY (2011 VS. 2015 VS. 2030)
5.2.1.5 Increasing investments, funds, and grants by public-private organizations
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE DIAGNOSTIC IMAGING MARKET
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulatory policies for medical devices
5.2.2.2 Clinical risks and complications associated with dermatology procedures
5.2.2.3 High cost of diagnostic imaging systems
5.2.2.4 Declining reimbursements and increasing regulatory
burden in the US
TABLE 3 MEDICARE REIMBURSEMENT TRENDS, BY IMAGING MODALITY, 2007–2019
5.2.3 OPPORTUNITIES
5.2.3.1 Growing medical devices industry in emerging economies
FIGURE 22 MEDICAL DEVICES MARKET, 2016–2020 (USD BILLION)
5.2.3.2 Increasing disposable income and expanding middle-class population
5.2.4 CHALLENGES
5.2.4.1 Competitive pricing by low-cost manufacturers and availability of low-cost substitutes
5.2.4.2 Dearth of trained professionals
5.2.5 TRENDS
5.2.5.1 Importance of artificial intelligence and teleradiology in skin disorder diagnosis and treatment
5.3 COVID-19 IMPACT ANALYSIS
5.4 RANGES/SCENARIOS
5.4.1 DERMATOLOGY DEVICES MARKET
FIGURE 23 REALISTIC SCENARIO
FIGURE 24 PESSIMISTIC SCENARIO
FIGURE 25 OPTIMISTIC SCENARIO
5.5 REGULATORY ANALYSIS
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DERMATOLOGY DEVICES
5.5.1 NORTH AMERICA
5.5.1.1 US
TABLE 5 US FDA MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
5.5.3.2 China
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 India
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT OF NEW ENTRANTS
5.6.2 THREAT OF SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 INTENSITY OF COMPETITIVE RIVALRY
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 26 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
5.8 VALUE CHAIN ANALYSIS
FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.9 ECOSYSTEM ANALYSIS
FIGURE 28 DERMATOLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS
5.9.1 ROLE IN ECOSYSTEM
FIGURE 29 KEY PLAYERS IN DERMATOLOGY DEVICES MARKET ECOSYSTEM
5.10 TECHNOLOGY ANALYSIS
5.11 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 10 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF
CONFERENCES & EVENTS
5.12 PATENT ANALYSIS
5.12.1 PATENT TRENDS FOR DERMATOLOGY DEVICES
FIGURE 30 PATENT TRENDS FOR DERMATOSCOPES, JANUARY 2011–JUNE 2022
FIGURE 31 PATENT TRENDS FOR LIPOSUCTION DEVICES, JANUARY 2011–JUNE 2022
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR DERMATOSCOPE PATENTS, JANUARY 2011—JUNE 2022
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS)
FOR LIPOSUCTION DEVICE PATENTS, JANUARY 2011—JUNE 2022
5.13 TRADE ANALYSIS
TABLE 11 IMPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 12 EXPORT DATA FOR HS CODE 901320, BY COUNTRY, 2017–2021 (USD MILLION)
5.14 PRICING ANALYSIS
TABLE 13 AVERAGE SELLING PRICES OF DERMATOLOGY DEVICES
TABLE 14 COST OF DERMATOLOGY TREATMENT DEVICES
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES
TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF DERMATOLOGY TREATMENT DEVICES (%)
5.15.2 BUYING CRITERIA
FIGURE 35 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF
DERMATOLOGY TREATMENT DEVICES
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR DERMATOLOGY DEVICE MANUFACTURERS
FIGURE 36 REVENUE SHIFT FOR DERMATOLOGY DEVICES
6 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 17 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 IMAGING DEVICES
6.2.1 MRI, ULTRASOUND, CT, AND OCT ARE WIDELY USED IN DERMATOLOGY DISEASE DIAGNOSIS
TABLE 18 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR IMAGING DEVICES, BY REGION, 2020–2027 (USD MILLION)
6.3 DERMATOSCOPES
6.3.1 INCREASING AWARENESS ABOUT SKIN HEALTH TO DRIVE SEGMENT GROWTH
TABLE 19 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR DERMATOSCOPES, BY REGION, 2020–2027 (USD MILLION)
6.4 MICROSCOPES
6.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED MICROSCOPES —
A KEY FACTOR DRIVING SEGMENT GROWTH
TABLE 20 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR MICROSCOPES, BY REGION, 2020–2027 (USD MILLION)
7 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 21 DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 SKIN CANCER DIAGNOSIS
7.2.1 RISING PREVALENCE OF SKIN CANCER AND INCREASING AWARENESS ABOUT EARLY DIAGNOSIS TO DRIVE SEGMENT GROWTH
TABLE 22 NUMBER OF MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
TABLE 23 NUMBER OF NON-MELANOMA SKIN CANCER CASES, BY COUNTRY (2020)
TABLE 24 NUMBER OF MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
TABLE 25 NUMBER OF NON-MELANOMA SKIN CANCER DEATHS, BY COUNTRY (2020)
TABLE 26 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR SKIN CANCER DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION)
7.3 OTHER DIAGNOSTIC APPLICATIONS
TABLE 27 DERMATOLOGY DIAGNOSTIC DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE
8.1 INTRODUCTION
TABLE 28 DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
8.2 LIGHT THERAPY DEVICES
8.2.1 INCREASING DEMAND FOR SKIN REJUVENATION PROCEDURES
TO DRIVE SEGMENT GROWTH
TABLE 29 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIGHT THERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION)
8.3 LASERS
8.3.1 IMPROVING LASER TECHNOLOGY HAS REVOLUTIONIZED TREATMENTS FOR SEVERAL SKIN CONDITIONS
TABLE 30 DERMATOLOGY TREATMENT DEVICES MARKET FOR LASERS, BY REGION, 2020–2027 (USD MILLION)
8.4 ELECTROSURGICAL EQUIPMENT
8.4.1 RISK OF ELECTROSURGICAL BURNS IS EXPECTED TO HINDER SEGMENT GROWTH
TABLE 31 DERMATOLOGY TREATMENT DEVICES MARKET FOR ELECTROSURGICAL EQUIPMENT, BY REGION, 2020–2027 (USD MILLION)
8.5 LIPOSUCTION DEVICES
8.5.1 INCREASING OBESITY RATES TO DRIVE SEGMENT GROWTH
TABLE 32 DERMATOLOGY TREATMENT DEVICES MARKET FOR LIPOSUCTION DEVICES, BY REGION, 2020–2027 (USD MILLION)
8.6 MICRODERMABRASION DEVICES
8.6.1 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE SEGMENT GROWTH
TABLE 33 DERMATOLOGY TREATMENT DEVICES MARKET FOR MICRODERMABRASION DEVICES, BY REGION, 2020–2027 (USD MILLION)
8.7 CRYOTHERAPY DEVICES
8.7.1 COST-EFFECTIVE NATURE OF CRYOTHERAPY TO DRIVE ITS ADOPTION
TABLE 34 DERMATOLOGY TREATMENT DEVICES MARKET FOR CRYOTHERAPY DEVICES, BY REGION, 2020–2027 (USD MILLION)
9 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 35 DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2 HAIR REMOVAL
9.2.1 IPL, DIODE, ND:YAG, AND RUBY LASERS ARE WIDELY USED IN HAIR REMOVAL PROCEDURES
TABLE 36 LASER HAIR REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 37 DERMATOLOGY TREATMENT DEVICES MARKET FOR HAIR REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.3 SKIN REJUVENATION
9.3.1 GROWING DEMAND FOR SAFE AND EFFECTIVE SKIN REJUVENATION TREATMENTS TO PROPEL SEGMENT GROWTH
TABLE 38 DERMATOLOGY TREATMENT DEVICES MARKET FOR SKIN REJUVENATION, BY REGION, 2020–2027 (USD MILLION)
9.4 ACNE, PSORIASIS, AND TATTOO REMOVAL
9.4.1 EMERGENCE OF LASER TECHNOLOGY FOR TATTOO REMOVAL TO DRIVE SEGMENT GROWTH
TABLE 39 LASER TATTOO REMOVAL PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 40 DERMATOLOGY TREATMENT DEVICES MARKET FOR ACNE, PSORIASIS, AND TATTOO REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.5 WRINKLE REMOVAL AND SKIN RESURFACING
9.5.1 RAPIDLY GROWING AGING POPULATION TO DRIVE SEGMENT GROWTH
TABLE 41 SKIN RESURFACING PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 42 DERMATOLOGY TREATMENT DEVICES MARKET FOR WRINKLE REMOVAL AND SKIN RESURFACING, BY REGION, 2020–2027 (USD MILLION)
9.6 BODY CONTOURING AND FAT REMOVAL
9.6.1 RISING AWARENESS OF RECONSTRUCTIVE SURGERY
TO DRIVE SEGMENT GROWTH
TABLE 43 LIPOSUCTION PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 44 NON-INVASIVE FAT REDUCTION (COOLSCULPTING, LIPOSONIX, EMSCULPT, VANQUISH, AND ZERONA) PROCEDURES: REGIONAL DISTRIBUTION (2020)
TABLE 45 DERMATOLOGY TREATMENT DEVICES MARKET FOR BODY CONTOURING AND FAT REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.7 VASCULAR AND PIGMENTED LESION REMOVAL
9.7.1 EMERGENCE OF LASER TECHNOLOGY FOR VASCULAR LESION REMOVAL TO DRIVE SEGMENT GROWTH
TABLE 46 DERMATOLOGY TREATMENT DEVICES MARKET FOR VASCULAR AND PIGMENTED LESION REMOVAL, BY REGION, 2020–2027 (USD MILLION)
9.8 WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT
9.8.1 CRYOTHERAPY IS WIDELY USED IN WART AND SKIN TAG TREATMENT
TABLE 47 DERMATOLOGY TREATMENT DEVICES MARKET FOR WARTS, SKIN TAGS, AND WEIGHT MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
9.9 OTHER TREATMENT APPLICATIONS
TABLE 48 DERMATOLOGY TREATMENT DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
10 DERMATOLOGY DEVICES MARKET, BY REGION
10.1 INTRODUCTION
TABLE 49 DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: DERMATOLOGY DEVICES MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US dominated North American market in 2021
TABLE 55 US: KEY MACROINDICATORS
TABLE 56 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 57 US: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 58 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 59 US: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 60 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 US: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 US: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Technological advancements in dermatology devices to drive market growth in Canada
TABLE 64 CANADA: KEY MACROINDICATORS
TABLE 65 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 CANADA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 CANADA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 69 EUROPE: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 70 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.1 FRANCE
10.3.1.1 Laws in France regarding cosmetic surgery are restrictive as compared with those in other countries
TABLE 74 FRANCE: KEY MACROINDICATORS
TABLE 75 FRANCE: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 76 FRANCE: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 77 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 FRANCE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 80 FRANCE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Rising disposable income to drive dermatology device adoption in Germany
TABLE 81 GERMANY: KEY MACROINDICATORS
TABLE 82 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 83 GERMANY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 84 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 85 GERMANY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 86 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Increasing focus on facial dermatology to aid market growth
TABLE 90 UK: KEY MACROINDICATORS
TABLE 91 UK: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 92 UK: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 93 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 UK: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 96 UK: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising number of plastic surgeons to drive market growth
TABLE 97 ITALY: KEY MACROINDICATORS
TABLE 98 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 99 ITALY: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 100 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 101 ITALY: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 102 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ITALY: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 105 ITALY: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing demand for cosmetic procedures to drive market growth
TABLE 106 SPAIN: KEY MACROINDICATORS
TABLE 107 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 108 SPAIN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 109 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 110 SPAIN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 111 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 SPAIN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 SPAIN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 115 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2020 (% OF GDP)
TABLE 116 RUSSIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 117 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 REST OF EUROPE: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 120 REST OF EUROPE: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 38 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET SNAPSHOT
TABLE 121 ASIA PACIFIC: DERMATOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 122 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 ASIA PACIFIC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Japan accounted for largest share of APAC market in 2021
TABLE 126 JAPAN: KEY MACROINDICATORS
TABLE 127 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 128 JAPAN: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 129 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 130 JAPAN: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 131 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 JAPAN: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 134 JAPAN: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Rising healthcare expenditure to drive market growth in China
TABLE 135 CHINA: KEY MACROINDICATORS
TABLE 136 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 CHINA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 CHINA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Improving healthcare infrastructure to drive market growth in India
TABLE 140 INDIA: KEY MACROINDICATORS
TABLE 141 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 142 INDIA: LEADING COSMETIC SURGICAL PROCEDURES IN 2019
TABLE 143 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2020
TABLE 144 INDIA: LEADING COSMETIC NON-SURGICAL PROCEDURES IN 2019
TABLE 145 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 INDIA: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 148 INDIA: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 149 THAILAND: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 150 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 ROAPAC: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 153 ROAPAC: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 154 MEXICO: KEY MACROINDICATORS
TABLE 155 BRAZIL: KEY MACROINDICATORS
TABLE 156 BRAZIL: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 157 MEXICO: LEADING COSMETIC SURGICAL PROCEDURES IN 2020
TABLE 158 ROW: DERMATOLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 159 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 ROW: DERMATOLOGY DIAGNOSTIC DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 162 ROW: DERMATOLOGY TREATMENT DEVICES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
11.3 REVENUE ANALYSIS
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN DERMATOLOGY TREATMENT DEVICES MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 40 DERMATOLOGY TREATMENT DEVICES MARKET SHARE ANALYSIS, 2020
TABLE 164 DERMATOLOGY TREATMENT DEVICES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX (KEY PLAYERS)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PARTICIPANTS
11.5.4 PERVASIVE PLAYERS
FIGURE 41 GLOBAL DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 42 DERMATOLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
11.7 COMPETITIVE BENCHMARKING
TABLE 165 DERMATOLOGY DEVICES MARKET: DETAILED LIST OF KEY SMES/START-UPS
TABLE 166 DERMATOLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF SMES/START-UPS
11.8 COMPANY FOOTPRINT
TABLE 167 OVERALL FOOTPRINT OF COMPANIES
TABLE 168 PRODUCT FOOTPRINT OF COMPANIES
TABLE 169 REGIONAL FOOTPRINT OF COMPANIES
11.9 COMPETITIVE SCENARIO AND TRENDS
11.9.1 DEALS
TABLE 170 DEALS, JANUARY 2019–MAY 2022
11.9.2 PRODUCT LAUNCHES & APPROVALS
TABLE 171 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MAY 2022
11.9.3 EXPANSIONS
TABLE 172 EXPANSIONS, JANUARY 2019–MAY 2022
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ALMA LASERS, LTD. (A SUBSIDIARY OF SISRAM MEDICAL LTD.)
TABLE 173 ALMA LASERS, LTD.: BUSINESS OVERVIEW
FIGURE 43 SISRAM MEDICAL LTD.: COMPANY SNAPSHOT (2021)
12.1.2 CUTERA, INC.
TABLE 174 CUTERA, INC.: BUSINESS OVERVIEW
FIGURE 44 CUTERA, INC.: COMPANY SNAPSHOT (2021)
12.1.3 CYNOSURE, INC.
TABLE 175 CYNOSURE, INC.: BUSINESS OVERVIEW
12.1.4 EL.EN. S.P.A.
TABLE 176 EL.EN. S.P.A.: BUSINESS OVERVIEW
FIGURE 45 EL.EN. S.P.A.: COMPANY SNAPSHOT (2021)
12.1.5 LUMENIS, LTD. (A SUBSIDIARY OF BOSTON SCIENTIFIC)
TABLE 177 LUMENIS, LTD.: BUSINESS OVERVIEW
FIGURE 46 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2021)
12.1.6 SOLTA MEDICAL (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
TABLE 178 SOLTA MEDICAL: BUSINESS OVERVIEW
FIGURE 47 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2021)
12.1.7 DERMLITE
TABLE 179 DERMLITE: BUSINESS OVERVIEW
12.1.8 BRUKER CORPORATION
TABLE 180 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.9 CARL ZEISS
TABLE 181 CARL ZEISS: BUSINESS OVERVIEW
FIGURE 49 CARL ZEISS: COMPANY SNAPSHOT (2021)
12.1.10 GENESIS BIOSYSTEMS, INC.
TABLE 182 GENESIS BIOSYSTEMS, INC.: BUSINESS OVERVIEW
12.1.11 HEINE OPTOTECHNIK GMBH & CO. KG
TABLE 183 HEINE OPTOTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW
12.1.12 MICHELSON DIAGNOSTICS, LTD.
TABLE 184 MICHELSON DIAGNOSTICS, LTD.: BUSINESS OVERVIEW
12.1.13 PHOTOMEDEX, INC. (A SUBSIDIARY OF DS HEALTHCARE GROUP)
TABLE 185 PHOTOMEDEX, INC.: BUSINESS OVERVIEW
12.1.14 FOTOFINDER SYSTEMS GMBH
TABLE 186 FOTOFINDER SYSTEMS GMBH: BUSINESS OVERVIEW
12.1.15 LEICA MICROSYSTEMS (A SUBSIDIARY OF DANAHER CORPORATION)
TABLE 187 LEICA MICROSYSTEMS: BUSINESS OVERVIEW
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
12.1.16 OLYMPUS CORPORATION
TABLE 188 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 51 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
12.1.17 CANDELA CORPORATION
TABLE 189 CANDELA CORPORATION: BUSINESS OVERVIEW
FIGURE 52 CANDELA CORPORATION: COMPANY SNAPSHOT (2020)
12.1.18 CANFIELD SCIENTIFIC, INC.
TABLE 190 CANFIELD SCIENTIFIC, INC.: BUSINESS OVERVIEW
12.1.19 BEIJING TOPLASER TECHNOLOGY CO., LTD.
TABLE 191 BEIJING TOPLASER TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SYNERON MEDICAL LTD. (A PART OF APAX PARTNERS)
12.2.2 AEROLASE
12.2.3 BOVIE (A SUBSIDIARY OF SYMMETRY SURGICAL)
TABLE 192 SYMMETRY SURGICAL: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The report “Dermatology Devices Market by Diagnostic Devices (Dermatoscope, Microscope, Imaging Techniques), Treatment Devices (Liposuction, Microdermabrasion, Lasers) & by Application (Cancer Diagnosis, Acne, Psoriasis, Hair Removal) - Global Forecast to 2019”.
The global dermatology devices market is expected to reach $11,337.0 million by 2019 from $6,578.23 million in 2014, growing at a CAGR of 11.50%.
he report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global dermatology devices market along with the estimates and forecasts of the revenue and market share analysis.
Rising incidence of skin disorders and increasing awareness for aesthetic procedures are the primary growth drivers for this market during the forecast period (2014–2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, reimbursement issues and stringent regulatory policies for medical devices may hinder the growth of this market.
The global dermatology devices market is segmented on the basis of applications and products. On the basis of products, the market is segmented into diagnostic and treatment devices. The diagnostic devices product segment is further subsegmented into dermatoscopes, microscope, and imaging techniques. Of these, the imaging techniques subsegment accounted for the largest share of the global dermatology diagnostic devices market in 2014. On the other hand, the treatment devices product segment is subsegmented into light therapy devices, lasers, electrosurgical equipment, liposuction devices, microdermabrasion, and cryotherapy devices.
The geographic segments included in this report are Asia, Europe, North America, and Rest of the World (RoW). North America includes Canada and the U.S. The Asian segment is further divided into China, India, Japan, and Rest of Asia.
